Depression and Anxiety Trial, Not Yet Recruiting NCT06545474 Sponsor: University Hospital Tuebingen Condition: Depression and Anxiety
Back to Depression And Anxiety

Depression and Anxiety Trial, Not Yet Recruiting

NCT06545474
Not Yet Recruiting Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People of any gender identity (male, female, or diverse)
  • People aged between 18 and 65 years
  • People diagnosed with moderate to severe major depression according to standard psychiatric criteria (DSM-5)
  • People with a depression symptom score of 20 or more on a standard rating scale called the MADRS
  • People whose current depressive episode has lasted at least 2 weeks but no longer than 2 years
  • People who have not previously taken antidepressant medication and for whom antidepressant treatment is considered appropriate
  • People who are able to understand and agree to take part in the study (give informed consent)

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People currently experiencing serious thoughts of suicide (as measured by a specific item on the MADRS rating scale)
  • People experiencing symptoms of psychosis (such as hallucinations or delusions)
  • People currently taking anti-seizure medications or sedative medications (benzodiazepines) above a certain dose level
  • People with an additional major psychiatric diagnosis alongside depression, with the exception of anxiety disorders
  • People with a severe personality disorder that is considered a primary concern
  • People whose depression has already not responded to at least one adequate antidepressant treatment in the current or a previous episode
  • People with certain neurological conditions, including serious brain injury, brain tumours, previous brain surgery, a stroke within the last 3 months, neurodegenerative diseases, epilepsy, or a history of seizures
  • People who have a cardiac pacemaker, as this is not compatible with MRI scanning
  • People who have metal implants inside the skull
  • People who have previously received a treatment called rTMS (repetitive transcranial magnetic stimulation)
  • People who have a device for deep brain stimulation
  • People with other serious physical health conditions, or who are pregnant
  • People for whom the study medication (escitalopram) is medically unsuitable (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 30 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

If you need support right now

This page includes language about suicide and self-harm, because that is how the trial's eligibility criteria are written. If reading it has been hard, you do not have to keep going. The services below are free, confidential, and answered by people trained for exactly this.

If you or someone else is in immediate danger, call 000.

  • Lifeline — 24/7 crisis support: 13 11 14
  • Suicide Call Back Service — 24/7 counselling: 1300 659 467
  • 13YARN — 24/7, for Aboriginal and Torres Strait Islander people: 13 92 76
  • Beyond Blue — 24/7 mental health support: 1300 22 4636
  • Emergency: 000

Outside Australia? The numbers above are Australian and will not work from overseas. Find a Helpline is a free directory of crisis lines in over 130 countries, run by ThroughLine with the International Association for Suicide Prevention. If you are in immediate danger, call your local emergency number.

Voxsanity is not a crisis service, and nothing on this page is medical advice. More Australian services are listed on our support lines page.

Contact this trial

Phone: +4970712984858

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Not Applicable
Sponsor
University Hospital Tuebingen
Registry
ClinicalTrials.gov
Start date
15 September 2024
Est. completion
31 December 2026

Primary endpoints

response rates after Stage I

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 30 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov